{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:07:02Z","timestamp":1792897622285,"version":"4.5.0"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.3201\/eid3007.240480","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T15:02:06Z","timestamp":1718204526000},"source":"Crossref","is-referenced-by-count":28,"title":["Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023\u2013February 2024"],"prefix":"10.3201","volume":"30","author":[{"given":"Mira C.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Noriel Q.","family":"Pascua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Kondor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa V.","family":"Gubareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3007.240480-202406121030-R1","doi-asserted-by":"publisher","first-page":"e00224","DOI":"10.1128\/CMR.00224-20","article-title":"Understanding the impact of resistance to influenza antivirals.","volume":"34","author":"Holmes","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid3007.240480-202406121030-R2","unstructured":"Centers for Disease Control and Prevention. Influenza antiviral drug resistance [cited 2024 Mar 18]. https:\/\/www.cdc.gov\/flu\/treatment\/antiviralresistance.htm"},{"key":"key-10.3201\/eid3007.240480-202406121030-R3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid1504.181280","article-title":"Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.","volume":"15","author":"Meijer","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3007.240480-202406121030-R4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"key-10.3201\/eid3007.240480-202406121030-R5","unstructured":"World Health Organization-Antiviral Working Group. Summary of neuraminidase (NA) amino acid substitutions assessed for their effects on inhibition by neuraminidase inhibitors (NAIs). 2023 Mar 7 [cited 2024 Mar 18]. https:\/\/cdn.who.int\/media\/docs\/default-source\/global-influenza-programme\/1.-nai_human_reduced-susceptibility-marker-table-(who)_07.03.23_update.pdf"},{"key":"key-10.3201\/eid3007.240480-202406121030-R6","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility \u2013 Geneva, November 2011 and June 2012.","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid3007.240480-202406121030-R7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2016.01.009","article-title":"Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance.","volume":"128","author":"Okomo-Adhiambo","year":"2016","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid3007.240480-202406121030-R8","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes.","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J Open Source Softw"},{"key":"key-10.3201\/eid3007.240480-202406121030-R9","unstructured":"Nextstrain. Real-time tracking of influenza A\/H1N1pdm evolution [cited 2024 Mar 18]. https:\/\/nextstrain.org\/flu\/seasonal\/h1n1pdm\/ha\/2y"},{"key":"key-10.3201\/eid3007.240480-202406121030-R10","doi-asserted-by":"crossref","unstructured":"Leung RC, Ip JD, Chen LL, Chan WM, To KK. Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoring. Lancet Microbe. 2024;S2666-5247(24)00037-5.","DOI":"10.1016\/S2666-5247(24)00037-5"},{"key":"key-10.3201\/eid3007.240480-202406121030-R11","doi-asserted-by":"publisher","first-page":"19884","DOI":"10.2807\/ese.16.23.19884-en","article-title":"Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation.","volume":"16","author":"Hurt","year":"2011","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid3007.240480-202406121030-R12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/infdis\/jis776","article-title":"A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility\u2014North Carolina and South Carolina, 2010-2011.","volume":"207","author":"Garg","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3007.240480-202406121030-R13","first-page":"969","article-title":"Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis\u2014North Carolina, 2009.","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid3007.240480-202406121030-R14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/infdis\/jiq010","article-title":"Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.","volume":"203","author":"Pizzorno","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3007.240480-202406121030-R15","doi-asserted-by":"publisher","first-page":"e22201","DOI":"10.1371\/journal.pone.0022201","article-title":"A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase.","volume":"6","author":"Bloom","year":"2011","journal-title":"PLoS One"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/7\/24-0480_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:38:21Z","timestamp":1732905501000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/7\/24-0480_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3007.240480","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}